Vir Biotechnology, Inc. (VIR)

9.71 -0.58 (-5.64%) USD  |  NASDAQ  |  May 07, 09:56
More

Vir Biotechnology Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for VIR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Hims & Hers Health, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Gossamer Bio, Inc. Upgrade
Sensei Biotherapeutics, Inc. Upgrade